Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEARL-MERIT: Methylprednisolone with EVT for Large Ischemic Stroke
NCT07175649Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Oct 2025
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in ischemic stroke comparing Methylprednisolone group with Placebo group (2 arms). Primary endpoint: Modified Rankin Scale Score 0-3 at 90 days. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
methylprednisolone sodium succinate
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07175649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07175649.